Quarterly ResultMay 19, 2026, 04:13 PM
Wellgistics Health Reports Q1 Net Loss of $7.74M; Going Concern Doubt
AI Summary
Wellgistics Health, Inc. reported a net loss of $7.74 million for the three months ended March 31, 2026, a significant improvement from the $32.43 million loss in the prior year period, but revenues declined sharply to $1.56 million from $10.86 million. The company faces substantial doubt about its ability to continue as a going concern due to its accumulated deficit of $118.77 million and low cash balance. Additionally, Wellgistics received Nasdaq deficiency notices for failing to meet minimum bid price and stockholders' equity requirements, risking delisting. Management is pursuing a reverse stock split, new financing, and a collaboration agreement to address these challenges.
Key Highlights
- Net loss for Q1 2026 was $7.74 million, compared to $32.43 million in Q1 2025.
- Net revenues decreased to $1.56 million in Q1 2026 from $10.86 million in Q1 2025.
- Cash and cash equivalents stood at $51,730 as of March 31, 2026.
- Accumulated deficit reached $118.77 million as of March 31, 2026.
- Net cash used in operating activities was $3.41 million for Q1 2026.
- Received Nasdaq deficiency notices for minimum bid price and $2.5 million stockholders' equity.
- Stockholders approved a reverse stock split (1-for-25 to 1-for-200) to regain Nasdaq compliance.
- Entered a collaboration agreement for a new LLC, with Wellgistics holding 51% ownership.
Price Impact
More from WGRX